Fri, 20 November 2015
Clinical Trial Spotlight: Options for EGFR Mutation-Positive Patients with T790M Mutation-Negative Acquired Resistance
Dr. Jack West reviews treatment options for patients with an EGFR activating mutation and acquired resistance but no T790M mutation, focusing on a clinical trial with the novel hypoxia-induced pan-HER inhibitor TH4000.
Direct download: GRACEcast-401_LCAM_2015_West_T790M_Neg_TH4000_Trial.mp4
Category:Lung-Cancer-Video -- posted at: 12:00pm PST